These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9255148)

  • 1. Staging recurrent metastatic colorectal carcinoma with PET.
    Delbeke D; Vitola JV; Sandler MP; Arildsen RC; Powers TA; Wright JK; Chapman WC; Pinson CW
    J Nucl Med; 1997 Aug; 38(8):1196-201. PubMed ID: 9255148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patients via colonoscopy who underwent positron emission tomography/computerized tomography due to colon involvement.
    Ekmen MÖ; Aksoy EK
    Rev Assoc Med Bras (1992); 2023; 69(10):e20230409. PubMed ID: 37792869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer.
    Honka MJ; Rebelos E; Malaspina S; Nuutila P
    Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
    Ozaki K; Harada K; Terayama N; Kosaka N; Kimura H; Gabata T
    Jpn J Radiol; 2020 Aug; 38(8):697-718. PubMed ID: 32246350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI) in Gastrointestinal Cancers.
    Matthews R; Choi M
    Diagnostics (Basel); 2016 Sep; 6(3):. PubMed ID: 27618106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET/CT Is Superior to Enhanced CT in Detecting Recurrent Subcentimeter Lesions in the Abdominopelvic Cavity in Colorectal Cancer.
    Yoon HJ; Lee JJ; Kim YK; Kim SE
    Nucl Med Mol Imaging; 2011 Jun; 45(2):132-8. PubMed ID: 24899992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current approaches and challenges for monitoring treatment response in colon and rectal cancer.
    McKeown E; Nelson DW; Johnson EK; Maykel JA; Stojadinovic A; Nissan A; Avital I; Brücher BL; Steele SR
    J Cancer; 2014 Jan; 5(1):31-43. PubMed ID: 24396496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal adenocarcinoma metastatic to the tonsil; PET-CT observations with pathological confirmation: A case report.
    He JP; Zhang S; Pang ZG; Li Q
    Oncol Lett; 2014 Jan; 7(1):153-155. PubMed ID: 24348839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers.
    Celik B; Yalcin AD; Bisgin A; Dimitrakopoulou-Strauss A; Kargi A; Strauss LG
    Med Sci Monit; 2013 Oct; 19():875-82. PubMed ID: 24145180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.
    Maas M; Rutten IJ; Nelemans PJ; Lambregts DM; Cappendijk VC; Beets GL; Beets-Tan RG
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1560-71. PubMed ID: 21468765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer - patterns of locoregional recurrence and distant metastases as demonstrated by FDG PET / CT.
    Purandare NC; Dua SG; Arora A; Shah S; Rangarajan V
    Indian J Radiol Imaging; 2010 Nov; 20(4):284-8. PubMed ID: 21423904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer.
    Lee JW; Kim SK; Lee SM; Moon SH; Kim TS
    Mol Imaging Biol; 2011 Jun; 13(3):565-572. PubMed ID: 20683670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells.
    Yun J; Rago C; Cheong I; Pagliarini R; Angenendt P; Rajagopalan H; Schmidt K; Willson JK; Markowitz S; Zhou S; Diaz LA; Velculescu VE; Lengauer C; Kinzler KW; Vogelstein B; Papadopoulos N
    Science; 2009 Sep; 325(5947):1555-9. PubMed ID: 19661383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.
    Coenegrachts K; De Geeter F; ter Beek L; Walgraeve N; Bipat S; Stoker J; Rigauts H
    Eur Radiol; 2009 Feb; 19(2):370-9. PubMed ID: 18795299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer.
    Chen LB; Tong JL; Song HZ; Zhu H; Wang YC
    World J Gastroenterol; 2007 Oct; 13(37):5025-9. PubMed ID: 17854148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer.
    Sarikaya I; Povoski SP; Al-Saif OH; Kocak E; Bloomston M; Marsh S; Cao Z; Murrey DA; Zhang J; Hall NC; Knopp MV; Martin EW
    World J Surg Oncol; 2007 Jul; 5():80. PubMed ID: 17634125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA.
    Sarikaya I; Bloomston M; Povoski SP; Zhang J; Hall NC; Knopp MV; Martin EW
    World J Surg Oncol; 2007 Jun; 5():64. PubMed ID: 17555577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer.
    Tateishi U; Maeda T; Morimoto T; Miyake M; Arai Y; Kim EE
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1627-34. PubMed ID: 17530248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
    Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M
    J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nuclear medical diagnostics for liver tumors].
    Buck AK; Stollfuss JC; Stahl A; Beer AJ; Meisetschläger G; Schwaiger M
    Internist (Berl); 2007 Jan; 48(1):21-4, 26-9. PubMed ID: 17195061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.